Blood Grouping Reagents Market Overview
The global blood grouping reagents market is estimated to acquire a valuation of over USD 2,642.17 million by the end of 2027. The report further projects that the market will register a growth rate of over 7.74% between 2021 – 2027.
Blood grouping reagents refer to the solutions which are used to distinguish MNS blood groups, Kell, Rhesus, and ABO. These groupings of human blood are depended on the presence or absence of antigens on the surface of red blood cells. The global market for blood grouping reagents has witnessed enormous growth in the past few years. The market’s growth is primarily propelled by the increasing occurrence of chronic disorders worldwide. Furthermore, the substantial increase in the spending in medical research across several regions is also likely to catalyze the market’s growth over the assessment era. On the other hand, the growing concerns relating to the efficiency and proficiency of test kits are anticipated to impede the market’s growth over the projected timeframe.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725
Blood Grouping Reagents Market Segment Analysis
The global market for blood grouping reagents has been divided into various segments based on product type, technique, test type, end-user, and region.
The blood grouping reagents market is split into instruments and consumables based on product.
By technique, the blood grouping reagents market is divided into serology, massively parallel sequencing techniques, assay-based techniques, PCR-based and microarray techniques, and others.
Based on test type, the global market for blood grouping reagents is split into antigen typing, antibody identification, antibody screening, coombs tests, cross-matching tests, and blood group and phenotype.
The blood grouping reagents market is split into clinical laboratories, blood banks, and hospitals based on end-user.
Blood Grouping Reagents Market Regional Analysis
The global blood grouping reagents market is examined across five major regions: North America, Asia-Pacific, Europe, South America, and the Middle East & Africa.
As per the MRFR reports, the North American region will secure the top position in the global blood grouping reagents market over the assessment era. The presence of major manufacturers is the primary aspect causing an upsurge in the regional market’s growth. Furthermore, the growing occurrence of chronic diseases causes an elevation in demand for organ transplants and blood transfusion. Moreover, the factors such as the growing awareness among the population, technological developments in the clinical segment, the growing number of launch new products & collaborations, and rising investments in research & collaborative approach are also anticipated to boost the regional market’s growth over the assessment era.
The blood grouping reagents market for the Asia-Pacific region is projected to register the maximum growth rate over the forecasted period. The regional market’s growth is attributed to the increasing prevalence of traumatic injuries from accidents and trauma. Furthermore, the growing demand for blood banking services, raising public awareness regarding blood donation, increasing road accidents causing traumatic injuries, and the increasing government initiatives are also estimated to boost the growth of the regional blood grouping reagents market over the forecasted era.
Blood Grouping Reagents Market Competitive Analysis
The global blood grouping reagents market has an incredibly competitive landscape. The players across the global market are focused on growing their global market reach and thus are implementing several growth policies. The market players compete based on aftermarket services, reliability, product quality, and cost. The global blood grouping reagents market has prominent leaders such as Aikang (China), Yuvraj Biobiz Incubator India Pvt (India), Ortho Clinical Diagnostics (US), DAY medical SA (Switzerland), Haemokinesis Pty Ltd (Australia), Novacyt Group (France), Merck KGaA (Germany), Tulip Diagnostics (India), Diagast SAS (France), Rapid Labs Ltd (UK), MTC Med. Produkte GmbH (Germany), Beckman Coulter, Inc (US), Bio-Rad Laboratories, Inc (US), and several others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-grouping-reagents-market-10725
Beckman Coulter, a leading player in the blood grouping reagents market, has disclosed the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The new system is completely automated, simplifying urinalysis workflow and lowering manual reviews to 4%. The latest model will be showcased in a live launch event held in the AACC Expo hall, booth 1523.
Browse Related Reports at:
eClinical Solutions Market Research Report – Global Forecast till 2027
Medical Marijuana Market Global Research Report – Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071